Gillian Reid Joins Chiltern International Ltd. As Key Account Director And Senior Business Development Executive

LONDON, Feb. 12 /PRNewswire/ -- Chiltern International, a leading global clinical research organization, announced that Gillian Reid has joined as Key Account Director and Senior Business Development Executive. Gillian brings 20 years of drug development experience to Chiltern in both the pharmaceutical and CRO industries.

Gillian is based in Edinburgh, Scotland and will be responsible for development of new business opportunities while being involved in the maintenance of relationships with selected clients. In her role she will report directly to Lewis Cameron, President Europe, and will be working across Europe and the United States.

“I am delighted to have been offered the opportunity to join such a dynamic group,” said Gillian. “Chiltern is strategically well positioned within the global CRO industry and with great services and product offerings further growth is to be anticipated.”

“I look forward to be working with Lewis Cameron, Chiltern’s European President, and with Diana Wood, Chiltern’s VP of Business Development in the United States. Both Lewis and Diana have a tremendous amount of experience in the industry. Their teams have done a great job at growing the company in Europe and the U.S. in recent years,” Gillian added.

“Gillian is a terrific addition to our Global Business Development Team,” Lewis Cameron, President Europe, commented. “Her understanding of the players and insights into the European and North American markets will help us further define our strategy as we continue to gain market share.”

Established in 1982, Chiltern is a leading global contract research organization with extensive experience of running and staffing international Phase I to Phase IV clinical trials across a broad therapeutic range for a wide variety of clients. Chiltern employs more than 900 people with 15 offices across the United States, United Kingdom, Germany, France, Italy, Spain, Poland, Czech Republic, Ukraine, India and South Africa. Chiltern provides services including Phase I and laboratory support, Phase II - III Clinical Development, Staff Resourcing, Biometrics, Regulatory and Medical Affairs. For further information see www.chiltern.com.

For More Information Contact: Catherine Lemercier Richard Baptista Chiltern International, Inc. Chiltern International Ltd. 2111 Palomar Airport Road 171 Bath Road Suite 200 Slough Carlsbad Berkshire CA 92011 SL1 4AA Tel: 1 (760) 707 5025 Tel: 44 (0) 1753 512 000 Fax: 1 (760) 707 5022 Fax: 44 (0) 1753 511 116 Email: Email: Catherine.Lemercier@chiltern.comRichard.Baptista@chiltern.com

Chiltern International

CONTACT: Catherine Lemercier of Chiltern International, Inc.,+1-760-707-5025, or fax +1-760-707-5022, orCatherine.Lemercier@chiltern.com; or Richard Baptista of ChilternInternational Ltd., +44-1753-512-000, or fax +44-1753-511-116, orRichard.Baptista@chiltern.com

MORE ON THIS TOPIC